AXIM Biotechnologies Expands Executive Team and Advisory

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AXIM Biotechnologies Expands Executive Team and Advisory Board With Finance and Pro Sports Leaders: Seth Yakatan and Marvin Washington

NEW YORK, Jan. 28, 2016 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies (OTC:AXIM) is proud to announce the following finance and community outreach-focused additions to the Company’s advisory board: 

Photos accompanying this release are available at 

http://www.globenewswire.com/NewsRoom/Attachm...854a5d475d

http://www.globenewswire.com/NewsRoom/Attachm...82127ca412   

“We are extremely fortunate to have attracted the proven industry leadership of Seth Yakatan and Marvin Washington,” states Dr. George E. Anastassov, MD, DDS, MBA, and Chief Executive Officer of AXIM ® Biotechnologies, Inc. “Both support AXIM’s mission and their added expertise will assist the Company in: affordably introducing new proprietary cannabis-based medicinal delivery methods, explaining the importance of solutions for health, wellness and sports injury prevention, and conveying to the public AXIM’s role in restoring hemp to the global economy.”

AXIM ® Biotech is currently in clinical trials for its patented cannabinoid-release chewing gum, MedChew RX™, for pain and spasticity with multiple sclerosis (MS). Another initiative of AXIM ® Biotech is to determine the effects of hemp-based cannabinoids on neurodegenerative conditions including post-traumatic stress disorder (PTSD) through research and clinical trials.

With more than two decades of financial industry experience, Yakatan’s background as a corporate finance professional includes: actively supporting small cap and major companies in achieving corporate, financing and asset monetization objectives through the successful structuring and management of strategic transactions and investments totaling more than $7 billion in value. Now focused on maximizing AXIM ® Biotech’s fiscal capabilities while ushering in cannabis’ return to the global healthcare industry, Yakatan is on AXIM ® ’s Advisory Board and is a consultant to the Company.  Click here for additional details on Yakatan’s background.

Washington is guiding AXIM ® Biotech in the role of Sports Advisor. The Super Bowl star has gone on the record discussing contact sports and his first-hand experience on the effects of head injuries, based on his stellar 11-year career in the NFL. He is actively explaining to the public and news media research behind the use of the non-psychoactive cannabinoid - cannabidiol (CBD) - to proactively address neuroprotection. Washington addresses members of the news media and industry groups including: sports (recreational, youth, collegiate and professional), military service members, military veterans, and individuals battling concussions and brain injury around the world.

Washington states, “I am very happy to be added to AXIM’s Board, as the Company continues to work to be one of the leaders in the medical cannabis industry.”   Click here for additional details on Washington’s background.

Dr. Anastassov continues, “AXIM Biotech is greatly appreciative of our entire Board of Advisors for their roles in advancing cannabinoid-based research and product development.” 

Focused upon unique proprietary delivery mechanisms for the introduction of cannabinoids (i.e. THC, CBD, CBG, CBN, etc.), AXIM ® Biotech is on a mission to find solutions for conditions for which there is currently no effective treatment including: MS , spasticity, pain, Parkinson’s disease, Alzheimer’s disease/ dementia , ADHD (attention deficit hyperactivity disorder), psychosis, PTSD, autism, RLS (restless leg syndrome), glaucoma, IBD, IBS, and Crohn’s disease.

Setting a major global example for “green” innovation and manufacturing, the plans of AXIM ® Biotech include creating a net negative carbon footprint in the environment.

AXIM ® Biotech has been featured by media outlets including: Reuters , Yahoo! Finance , Marketwatch , ABC , NBC , CBS , Telemundo , WGN, Univision, Marijuana Investor News , FOX Business , MainStreet.com , MJ Freeway , Chemical & Engineering News , Dental Tribune , Pharmaceutical Commerce , Dental Products Report and MJI News . For more information, visit AXIM Biotech’s website .

To arrange for media interviews, contact Andrew Hard, Public Relations Spokesperson, at Andrew.Hard@AXIMBiotechnologies.com or call 888-829-0070.

About AXIM ® Biotechnologies:

AXIM ® Biotechnologies (OTC:AXIM) is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products where we prioritize the well-being of our customers while embracing a solid fiscal strategy.  For more information, visit the Company website at www.AXIMBiotech.com .

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of AXIM ® Biotechnologies, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

AXIM ® Biotechnologies does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell, and distribute hemp-based products.

The photo is also available at Newscom,  www.newscom.com , and via AP PhotoExpress.

Contact Info North American Address: 18 East 50th Street, 5 Floor New York, NY 10022 +1 844 294 6246 European Address: Boelewerf 32, Unit 3 2987 VD Ridderkerk, The Netherlands +31 10 8209 227

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 152

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 157

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 84

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 227

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 111

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 182

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 26

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 135

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading

Top 5 Most Recently Viewed Articles

Social Media Buzz Powers Hainan's Travel Boom

Updated Category News Views 205

Social Media Buzz Powers Hainan's Travel Boom This year marks a remarkable shift in Hainan's tourism, driven by the advent of visa-free travel access for international visitors. As the beautiful island in southern China opens its doors wider, a surge in travelers, especially travel bloggers from around the globe, is noticeable. Influencers from diverse backgrounds,...

Continue Reading
Kodiak Sciences Reports Q3 2025 Financial Milestones and Updates

Updated Category News Views 375

Kodiak Sciences Reports Q3 2025 Financial Milestones and Updates Kodiak Sciences Inc. (Nasdaq: KOD) has recently shared significant business highlights along with financial results for the third quarter of 2025. This biotechnology company is making strides in the field of retinal medicine. 'We are witnessing a period marked by sustained momentum,' expressed Victor...

Continue Reading
Vaisala Initiates Share Repurchase Program to Enhance Incentives

Updated Category News Views 193

Vaisala’s Strategy for Share Repurchases Vaisala Corporation is embarking on an important journey to repurchase its own shares as part of a broader incentive plan. This strategic decision follows the authorization granted by the Annual General Meeting, reflecting the company's commitment to fostering a rewarding environment for its employees. As a key player in climate...

Continue Reading
Investigating Customer Bancorp, Inc. Losses: Understand Your Rights

Updated Category News Views 92

Exploring Customers Bancorp, Inc.'s Recent Challenges Customers Bancorp, Inc., identified by the ticker CUBI, is dealing with significant accusations regarding the truthfulness of the business information it has shared with the public. The Rosen Law Firm, a respected advocate for investor rights, is currently looking into securities claims tied to these allegations. If...

Continue Reading
Allurity and Onevinn: Transforming Cybersecurity Together

Updated Category News Views 374

Allurity Expands its Cybersecurity Portfolio with Onevinn Acquisition Allurity, a prominent European provider of cybersecurity services, has exciting news to share. The company has taken a significant step forward by acquiring Onevinn, a Swedish company renowned for its intelligent security and managed services. This move not only showcases Allurity's ambitions but also...

Continue Reading